Patient Protection and Affordable Care Act2018-12-13T23:28:50+00:00
902, 2024

Top 10 Tips and Tricks for Remediating Data Issues and Reporting Your Transparency Data

By |February 9th, 2024|Blog|

Life sciences professionals engaged in transparency reporting understand the myriad of challenges in compiling necessary data for reporting. Navigating challenges such as incomplete records, discrepancies among data sources, duplicate, or late data submissions can significantly compromise the accuracy of reporting. Compliance and transparency teams often endure heightened stress and sleepless nights over these common issues, [...]

202, 2024

Navigating Recent Global Legislative Updates in the Life Science Industry

By |February 2nd, 2024|Blog|

MediSpend’s legal experts recently presented a webinar shedding light on the recent transparency updates within the life science industry. The presentation covered key topics, such as updates to CMS’ Open Payments reporting, various state considerations and the newly issued OIG General Compliance Program Guidance. Notably, the webinar highlighted recent developments in compliance regulations in both Italy and [...]

2711, 2023

OIG Issues General Compliance Program Guidance

By |November 27th, 2023|Blog|

On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 Health Care Compliance Association’s (HCCA) Healthcare Enforcement Compliance Conference, published the General Compliance Program Guidance (GCPG) as a revised reference guide for the healthcare compliance community and other healthcare stakeholders. During [...]

111, 2023

Legislative Watch Updates

By |November 1st, 2023|Blog|

MediSpend’s Advisory Services team recently presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Connecticut’s new sales representative disclosure requirements and an update on the Italian Sunshine Act. CMS Open Payments Updates Numerous [...]

2107, 2023

CMS Publishes 2022 Open Payments Data

By |July 21st, 2023|Blog|

The Centers for Medicare and Medicaid Services (CMS) recently published their 2022 Open Payments data as well as newly submitted and updated payment records for previous program years. The 2022 publication includes transactions that took place between January 1st and December 31st. Applicable manufacturers reported $12.59 billion in reportable payments, ownership and investment interests to [...]

604, 2023

Sanctions Screening Service is a Win-Win for Life Sciences Organizations

By |April 6th, 2023|Blog|

Life sciences organizations are subject to numerous legal and regulatory requirements, including an obligation to screen the healthcare professionals and organizations (HCP/Os) that they contract and engage with to ensure they are not caught off guard by any infractions that exist, a process known as sanctions screening. Sanctions screening involves verifying these individuals and entities [...]

1602, 2023

Legislative Watch Updates Around the Globe

By |February 16th, 2023|Blog|

Recently, MediSpend’s Advisory Services team presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Oregon’s new sales representative disclosure requirements, the Italian Sunshine Act and the Chilean Chamber of Pharmaceutical Innovation (CIF) disclosure [...]

702, 2023

Introducing MediSpend’s 2022 Cultural Representatives

By |February 7th, 2023|News|

At MediSpend, we’re on a mission to empower life sciences companies to grow their business compliantly through our best-in-class software solutions and top-rated client services. To achieve this mission, we’ve assembled an incredible team and have laid a foundation of cultural attributes that help us make a difference in the life sciences industry. Each year, [...]

1701, 2023

MediSpend Reports Exponential Growth in 2021

By |January 17th, 2023|News|

January 18, 2022 Portsmouth, NH — MediSpend, a global technology company providing best-in-class solutions that empower life sciences companies to grow their business compliantly, reports another year of record-breaking growth with the addition of various new clients totaling nearly 150 life sciences companies leveraging the MediSpend Global Compliance Suite. With support from their new investor, [...]

1701, 2023

MediSpend Provides Glimpse into the Future

By |January 17th, 2023|News|

Continued rapid growth leading to new innovations that further enable compliant HCP engagements. Portsmouth, NH - July 27, 2021— MediSpend, a global technology company providing advanced, best-in-class compliance solutions for the life sciences industry, provides a glimpse into the future as rapid growth continues to fuel new product development and an expanded partner program further [...]

Go to Top